03/16/23 6:50 AMNYSE : BDX BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious VaginitisBD, a leading global medical technology company, today announced that it has received 510 clearance from the U.S. Food and Drug Administration for the BD Vaginal Panel on the BD COR™ System, a comprehensive diagnostic test that directly detects the three most common infectious causes of vaginitis using BD's high-throughput molecular diagnostic platform for...RHEA-AIneutral
03/01/23 4:15 PMNYSE : BDX conferencesBD to Present at Barclays Global Healthcare ConferenceBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 9:00 am Eastern Time.The live webcastRHEA-AIneutral
02/21/23 4:15 PMNYSE : BDX conferencesBD to Present at Cowen 43rd Annual Healthcare ConferenceBD, a leading global medical technology company, today announced that it will present at the Cowen 43 rd Annual Healthcare Conference on Monday, March 6, 2023 at 9:50 am Eastern Time. The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage...RHEA-AIneutral
02/21/23 6:50 AMNYSE : BDX fda approvalBD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap TestBD, a leading global medical technology company, today announced U.S. Food and Drug Administration market approval for the BD Onclarity™ HPV Assay to be used with the ThinPrep ® Pap Test. The BD SurePath™ Liquid-based Pap Test vial and the Hologic ThinPrep ® Pap Test PreservCyt ® Solution vial are the two most common Pap vials used by laboratories in the United...RHEA-AIvery positive
02/15/23 11:53 AMNYSE : BDX BD Named as One of America's Best Large EmployersBD, a leading global medical technology company, announced that the company has been named to America's Best Large Employers List 2023 by Forbes, furthering its progress against the company's environmental, social and governance strategy. "This recognition is a reflection of our continued commitment to build on our already strong culture where our...RHEA-AIneutral
02/08/23 6:50 AMNYSE : BDX covid-19BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination TestBD, a leading global medical technology company, today announced that it has received Emergency Use Authorization from the U.S. Food and Drug Administration for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A+ B and Respiratory Syncytial Virus to help combat illness in the current and future respiratory virus seasons.RHEA-AIneutral
02/03/23 6:50 AMNYSE : BDX BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific DiscoveryBD, a leading global medical technology company, today announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity– potentially accelerating time to discovery across a wide range of disciplines including immunology, genetic disease research, and...RHEA-AIneutral
02/02/23 6:30 AMNYSE : BDX earningsBD Reports First Quarter Fiscal 2023 Financial ResultsBD, a leading global medical technology company, today announced results for its first quarter of fiscal 2023, which ended December 31, 2022. "Our strong performance in Q1 reflects the momentum of our BD 2025 strategy, driven by a combination of innovation and continued strong execution," said Tom Polen, chairman, CEO and president of BD. On April 1, 2022, the Company...RHEA-AIpositive
01/31/23 8:07 AMNYSE : BDX BD Named to Bloomberg Gender-Equality Index for 4th Consecutive YearBD, a leading global medical technology company, today announced that it has been named to the 2023 Bloomberg Gender-Equality Index, marking the fourth consecutive year the company has been recognized on the index. BD increased its scores across all pillars with noted improvements in external brand and female leadership and talent pipeline.RHEA-AIpositive
01/25/23 6:50 AMNYSE : BDX BD Publishes 2022 Cybersecurity Annual ReportBD, a leading global medical technology company, today released its third annual cybersecurity report to update stakeholders about the company's ongoing efforts to advance cybersecurity maturity, protect against cyberattacks and empower customers with information about cyber risks and vulnerabilities. Through the BD 2022 Cybersecurity Annual...RHEA-AIneutral